• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Key mutations may protect against coronary artery disease

byJon LiuandXu Gao
November 13, 2014
in Cardiology, Chronic Disease, Genetics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Genetic mutations that led to the inactivation NPC1L1, a lipid transporter protein, were linked to lower low-density lipoprotein (LDL) and total cholesterol levels.

Evidence Rating Level: 2 (Good)

Study Rundown: Ezetimibe is a lipid-lowering agent thought to block lipid absorption by inhibiting the Niemann-Pick C1-like 1 gene (NPC1L1), which codes for a protein that transports cholesterol from the gut lumen into enterocytes. Previous genome-wide studies have demonstrated an association between low-density lipoprotein (LDL) levels and genetic sequence variation in NPC1L1. Elevated LDL is a well-known risk factor for coronary artery disease.

This genetic study combined data collected internationally from prior case-control and cohort studies. Initially, a total of 15 common “inactivating mutations” were identified in the exon (protein-coding) regions of NPC1L1. Patients who were carriers of one of the 15 inactivating mutations were noted to have statistically significant reductions in both LDL and total cholesterol (as compared to non-carriers). Among patients with established coronary heart disease, carrier frequency for one of the 15 inactivating mutations was 0.04% versus 0.09% in those without coronary heart disease.

As only inactivating mutations were examined, the lipid-lowering effect of NPC1L1 mutations may have been understated as other types of mutations were not included in this study (e.g., frame-shift, splice-site). Furthermore, other phenotypic consequences of NPC1L1 mutations were not studied therefore the lipid lowering benefits may be offset by other uncharacterized changes. This study once again emphasizes the importance of genetic predisposition when considering a patient’s risk of coronary heart disease. Future studies are likely to focus on the clinical impact of earlier NPC1L1 blockade as a form of primary prophylaxis against coronary heart disease.

Click to read the study, published today in NEJM

Relevant Reading: Niemann-Pick C1-Like 1 (NPC1L1) Protein in Intestinal and Hepatic Cholesterol Transport

RELATED REPORTS

Olpasiran significantly reduces lipoprotein(a) levels in patients with cardiovascular disease

Risk of myopathy and myalgia among statin users may be small and clinically insignificant

#VisualAbstract: Functional testing nonsuperior to routine care for percutaneous coronary intervention patients

In-Depth [genetic analysis study]: This study included data from 16 prior case-control and cohort studies. After sequencing NPC1L1 from approximately 21,000 patients, a total of 15 inactivating mutations were identified in 34 patients (“carriers”). When compared to non-carriers, carriers had lower levels of total cholesterol (0.34 mmol/L, p=0.03) and LDL (0.31 mmol/L, p=0.04). No statistical difference was noted in triglyceride levels or high-density lipoprotein (non-carriers vs. carriers). Carrier frequency was lower (0.04%) in the group with coronary heart disease versus the group without coronary heart disease (0.09%), leading to a risk reduction of 53% among carriers (p=0.008).

More from this author: Rituximab superior to azathioprine in autoimmune vasculitis, Ultrasound as effective as CT at identifying high-risk kidney stones, reduces radiation exposure, Lower blood transfusion threshold in septic shock safe at 90-days, Influenza vaccination in pregnancy protects both mother and infant, Sirolimus may prevent graft failure in patients with renal transplantation for antiphospholipid syndrome

Image: PD

©2014 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. No article should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2 Minute Medicine, Inc.

Tags: cholesterolCoronary artery diseaseLDL
Previous Post

Morbid obesity increases risk for cervical cancer death

Next Post

Smokers’ support for plain tobacco packaging linked to desire to quit

RelatedReports

Ivabradine ineffective in stable coronary artery disease [SIGNIFY trial]
Cardiology

Olpasiran significantly reduces lipoprotein(a) levels in patients with cardiovascular disease

November 22, 2022
Gender conformity influences use of laxatives and muscle-building products
Cardiology

Risk of myopathy and myalgia among statin users may be small and clinically insignificant

September 20, 2022
#VisualAbstract: Functional testing nonsuperior to routine care for percutaneous coronary intervention patients
StudyGraphics

#VisualAbstract: Functional testing nonsuperior to routine care for percutaneous coronary intervention patients

September 14, 2022
Colchicine may lower the risk of cardiovascular events in patients with coronary disease
Cardiology

Fractional flow reserve guidance for percutaneous coronary intervention is similar to intravascular ultrasonography guidance

September 1, 2022
Next Post
Number of lives saved due to tobacco control continues to rise

Smokers' support for plain tobacco packaging linked to desire to quit

Vitamin deficiency may persist after Omega-loop gastric bypass

Vitamin deficiency may persist after Omega-loop gastric bypass

Chronic marijuana use linked to structural differences in the brain

Chronic marijuana use linked to structural differences in the brain

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Rocatinlimab may be effective in the treatment of moderate-to-severe atopic dermatitis
  • Gender-affirming hormones improve psychosocial functioning in transgender youth
  • Left atrial reservoir strain improves ischemic stroke risk prediction in low-risk patients
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options